Inventaire - your friends and communities are your best library - Inventaire

Primary or secondary prevention for AD: who cares?

author

Giovanni B. Frisoni

John Q. Trojanowski

published in: Lancet Neurology

date of publication: 2012-06-15

Cites articles 5

Date

Title

Authors

2012-07-01

Colombia at the centre of preclinical AD research
2011-09

Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets
2011-05

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Laurel A. Beckett, Clifford Jack, Jeffrey Kaye, Yaakov Stern, David A Bennett, Maria C Carrillo, Anne M Fagan, Eric M. Reiman, Kristine Yaffe, Paul S. Aisen, Reisa Sperling, Eric R Siemers, Suzanne Craft, Marcelle Morrison-Bogorad, Creighton H Phelps, Thomas J Montine
2007-06-01

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

William E. Klunk, Howard J Aizenstein, Steven T Dekosky
2007-02-09

The topography of grey matter involvement in early and late onset Alzheimer's disease.

Giovanni B. Frisoni, Michela Pievani, Paul M. Thompson, Arthur W. Toga, Kiralee M. Hayashi, Cristina Testa, Francesca Sabattoli, Lorena Bresciani, Matteo Bonetti, Alberto Beltramello

Article - wd:Q42466557

Welcome to Inventaire

the library of your friends and communities

you are offline